Ncardia B.V. – Trademark Portfolio
Entity Type: 99
Ncardia B.V. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 6 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include NCYTE, PULSE, and CELLISTIC.
Galileiweg 8
NL-2333 BD Leiden
Showing of trademarks Trademarks
Trademark Classifications
Ncardia B.V.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Ncardia B.V. have?
Ncardia B.V. has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 1 abandoned.
What trademark classes does Ncardia B.V. file in?
Ncardia B.V. files trademarks across 6 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Ncardia B.V.'s most well-known trademarks?
Ncardia B.V.'s registered trademark portfolio includes well-known marks such as NCYTE, PULSE, and CELLISTIC. These are among 5 currently registered trademarks in the portfolio.
What is Ncardia B.V.'s trademark registration success rate?
Ncardia B.V. has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.